Company intelligence
Hypertrophic Cardiomyopathy Association
The HCMA provides support, education, advocacy, access to research, understanding and care to those with HCM.
About Hypertrophic Cardiomyopathy Association
The HCMA is the preeminent organization improving the lives of those with hypertrophic cardiomyopathy, HCM, preventing untimely deaths and advancing global understanding. Founded in 1996 we are committed to providing support, education, advocacy and advancing research, understanding and care to those with HCM.
Verified activity
Signals from Hypertrophic Cardiomyopathy Association
10 published signals
Partnerships
Hypertrophic Cardiomyopathy Association partnered with UCSF Health in San Francisco, CA to establish an HCMA Recognized Center of Excellence.
Reported by Hypertrophic Cardiomyopathy Association
Research & Knowledge
Hypertrophic Cardiomyopathy Association announced that Lisa is joined by HCM specialist Dr. Anjali Owens to discuss EDG-7500, an investigational treatment for HCM, and the CIRRUS-HCM clinical trial in people with obstructive and non-obstructive HCM.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association announced that Lisa is joined by HCM specialist Dr. Harry Lever to discuss atrial fibrillation, emerging therapies for managing obstruction, and how understanding your anatomy can improve your mental and physical well-being while living with hypertrophic cardiomyopathy.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association announced that Dr. Harry Lever and Lisa will discuss septal reduction options and emerging therapies to manage obstruction on September 4th at 11am EST.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association announced that Dr. Anjali Owens and Lisa will discuss EDG-7500 and the CIRRUS-HCM clinical trial at the CIRRUS-HCM clinical trial on September 4th at 12:15pm EST.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association is hosting a live event on September 8 featuring international and Filipino experts on the future of HCM care and advocacy in the Philippines.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association announced that Lisa is joined by HCM specialist Dr. Anjali Owens to discuss EDG-7500 and the CIRRUS-HCM clinical trial on September 4th at 12:15pm EST.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association hosted a live discussion on septal reduction options and emerging therapies to manage obstruction on Friday, September 4th at 11am EST with Lisa and Dr. Harry Lever.
Reported by Hypertrophic Cardiomyopathy Association
Research & Knowledge
Hypertrophic Cardiomyopathy Association announced that Lisa Salberg and Dr. Martin Maron from the ACACIA-HCM trial discussed groundbreaking results from the trial live from ESC in Munich.
Reported by Hypertrophic Cardiomyopathy Association
Presence & Recognition
Hypertrophic Cardiomyopathy Association hosted a conversation between Lisa Salberg and Dr. Michael Ayres discussing HCM symptoms, care team recognition, back-to-school planning, beta blockers, cardiac scarring, autonomic symptoms, and the changing treatment toolbox on August 21, 2026.
Reported by Hypertrophic Cardiomyopathy Association